Skip to main content

Marta Riba Barroso

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Marta Riba Barroso

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Laura Fresno Bermejo

Laura Fresno Bermejo

Senior researcher
Protein kinases in cancer research
Read more
Jessica Souto Higueras

Jessica Souto Higueras

Predoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Cristina Dopazo Taboada

Cristina Dopazo Taboada

Main researcher
General Surgery
Read more
Irene Buera Surribas

Irene Buera Surribas

Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.